Company: BLNE
Filing Date: 2025-11-14
Form Type: 424B3
Source: 0001493152-25-023493
Chunk: 19

Company: Beeline Holdings, Inc.
Filing Date: 2025-11-14
Form: 424B3
Chunk 19
---
 are based on the exercise price as adjusted to $0.66 and proportionate adjustment to the number of shares, which is subject to shareholder approval.

(7) Represents the number of shares of common stock being offered hereby.

| 14 |

<div align='center'>MARKET INFORMATION</div>

Our common stock is listed on The Nasdaq Capital Market (“Nasdaq”) under the symbol “BLNE.”

On November 10, 2025, the last reported sale price of our common stock on Nasdaq was $2.11 per share. As of November 10, 2025, we had approximately 183 stockholders of record. As of that date, a total of 16,509,150 shares of our common stock were held in street name by additional beneficial owners. The actual number of holders of our common stock is greater than this number of record holders and includes stockholders who are beneficial owners, but whose shares are held in street name by brokers or held by other nominees. This number of holders of record also does not include stockholders whose shares may be held in trust by other entities.

<div align='center'>DIVIDEND POLICY</div>

We have never declared nor paid any cash dividends on our common stock, and currently intend to retain all our cash and any earnings for use in our business and, therefore, do not anticipate paying any cash dividends in the foreseeable future. Any future determination to pay cash dividends on our common stock will be at the discretion of the Board of Directors and will be dependent upon our consolidated financial condition, results of operations, capital requirements and such other factors as the Board deems relevant.

<div align='center'>SELLING STOCKHOLDER</div>

This prospectus relates to the possible resale from time to time by C/M of any or all of the shares of common stock that may be issued by us to C/M under the Purchase Agreement. For additional information regarding the issuance of common stock covered by this prospectus, see the section titled “C/M Committed Equity Financing” above. We are registering the shares of common stock pursuant to the provisions of the Registration Rights Agreement we entered into with C/M on March 7, 2025 in order to permit the Selling Stockholder to offer the shares for resale from time-to-time. Except for the transactions contemplated by the Purchase Agreement and the Registration Rights Agreement and as disclosed elsewhere in this prospectus or the information incorporated by reference herein (which include C/M and its affiliates’ roles as investor or lender in previous transactions with the Company